Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Magnesium: current studies--critical evaluation--consequences]

T Meinertz1

  • 1Abteilung für Kardiologie, Universitätskrankenhaus Eppendorf, Hamburg.

Zeitschrift Fur Kardiologie
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular outcome in type 2 diabetes and atrial fibrillation.

Herz·2018
Same author

[Not Available].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author

Frequency and covariates of fear of death during myocardial infarction and its impact on prehospital delay: findings from the multicentre MEDEA Study.

Clinical research in cardiology : official journal of the German Cardiac Society·2015
Same author

[Diabetes mellitus--risk factor for atrial fibrillation. Potential therapeutic implications].

Herz·2014
Same author

[Preventive pacing in patients with paroxysmal atrial fibrillation: programming and follow-up of patients with dual-chamber pacemakers and triggered preventive pacing functions].

Herzschrittmachertherapie & Elektrophysiologie·2014
Same author

[Anticoagulation control according to pharmacogenetic or clinical parameters? - Genotyped-guided dosing provides no advantages].

Deutsche medizinische Wochenschrift (1946)·2014

Intravenous magnesium effectively treats certain heart rhythm disorders. However, its use in acute myocardial infarction, heart failure, and hypertension is still debated and not standard practice.

Area of Science:

  • Cardiology
  • Clinical Pharmacology
  • Electrophysiology

Context:

  • Magnesium's role in cardiovascular health is increasingly recognized.
  • Numerous studies have investigated magnesium's therapeutic potential in various cardiovascular conditions.
  • Evidence supports its efficacy in specific arrhythmias but remains inconclusive for others.

Purpose:

  • To review the therapeutic efficacy of magnesium in cardiovascular diseases.
  • To differentiate established uses from controversial applications of magnesium therapy.
  • To assess magnesium's current standing in treating arrhythmias, myocardial infarction, heart failure, and hypertension.

Summary:

  • High-dose intravenous magnesium is established for treating supraventricular and ventricular arrhythmias, including Torsade de pointes-tachycardia.

Related Experiment Videos

  • The efficacy of magnesium in acute myocardial infarction, congestive heart failure, and arterial hypertension is not definitively proven.
  • Magnesium is not considered a standard therapy for acute myocardial infarction.

    • Impact:

    • Clarifies the established and controversial applications of magnesium in cardiovascular medicine.
    • Provides a basis for clinical decision-making regarding magnesium supplementation.
    • Highlights areas requiring further controlled research to establish definitive therapeutic guidelines.